NCT05769699
Recruiting
Not Applicable
Serum Biomarkers in Parkinson's Disease at Different Stages
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 site in 1 country200 target enrollmentFebruary 10, 2022
ConditionsParkinson Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Parkinson Disease
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Determine clinical characteristics of parkinsonian patients in various stages of disease
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
- Determine clinical characteristics of parkinsonian patients in various stages of disease;
- Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease.
- Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria;
- •Age: 18-80 years;
- •Signature of informed consent to participate in this study
- •Exclusion criteria.
- •Women pregnant
- •Inflammatory or autoimmune diseases
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Determine clinical characteristics of parkinsonian patients in various stages of disease
Time Frame: 3 years
Determine clinical characteristics of parkinsonian patients in various stages of disease by means of NMS score changes.
Determine biooogical characteristics of parkinsonian patients in various stages of disease
Time Frame: 3 years
dosage of serum IL-1b, IL6, IL-5, IL-4, IL17, TNFa, IFNg, IL10, total-alpha-synuclein, NfL, BDNF (ng/ml for all)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Biomarkers for differentiation of Parkinson*s disease subtypes.Parkinson's10028037NL-OMON39292eids Universitair Medisch Centrum210
Recruiting
Not Applicable
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian SyndromeProgressive Supranuclear PalsyMultiple System AtrophyParkinson's DiseaseNCT06490926Fujian Medical University Union Hospital180
Completed
Not Applicable
Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled BreathParkinson's DiseaseParkinsonismNCT01246336Rambam Health Care Campus41
Recruiting
Not Applicable
Biomarkers in Parkinsonian SyndromesParkinsonian SyndromesParkinson's DiseaseMultiple System AtrophyProgressive Supranuclear PalsyNCT02114242University Hospital, Bordeaux100
Recruiting
Not Applicable
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using NeuroimagingParkinson DiseaseMultiple System AtrophyProgressive Supranuclear PalsyNCT03872102University of Texas Southwestern Medical Center90